Replimune Group, Inc.'s RP1 has failed at the FDA twice, but Makary's resignation keeps a resubmission possible. REPL's cash runway stands at under a year; workforce cuts and RP1 discontinuation are ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

This price reflects trading activity during the overnight session on the Blue Ocean ATS, available 8 PM to 4 AM ET, Sunday through Thursday, when regular markets are closed. The above button links to ...

Federal prosecutors ripped down hundreds of artificial intelligence-generated phony social media accounts used by Russian operatives to create a "bot farm" that spread lies and pro-Vladimir Putin ...

Are you unable to join a server on Discord? Discord is a VoIP and instant messaging service that allows you to communicate through voice calls, video calls, text messaging, and file sharing. It allows ...

ChatGPT started the AI revolution, but it isn't the only chatbot worth using. We've tested the top AI chatbots to help you determine which one is right for you. I’ve been writing about consumer ...

Nathan Reiff has been writing expert articles and news about financial topics such as investing and trading, cryptocurrency, ETFs, and alternative investments on Investopedia since 2016. Erika Rasure ...

Adam Hayes, Ph.D., CFA, is a financial writer with 15+ years Wall Street experience as a derivatives trader. Besides his extensive derivative trading expertise, Adam is an expert in economics and ...

Any agent framework can use this to give its agent a single python tool that has every MCP tool pre-loaded as an async function. The agent writes Python code to call them — with loops, conditionals, ...

A real Claude Code-style terminal workflow in Python: stream replies, call tools, fetch context, and extend behavior with skills.

Replimune Group, Inc. is a clinical-stage biotechnology company. It engages in the business of developing oncolytic immunotherapies for the treatment of cancer. The company was founded by Philip ...